4D pharma plc Retained Earnings
4D pharma plc had Retained Earnings of -$180.17 million as of 2021-12-31, per its 20-F filed 2022-03-31.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2022-03-31
- 2021-12-31: Retained Earnings (Accumulated Deficit) -$180.17M; Retained Earnings (Accumulated Deficit) as first filed $173.20M.
- 2021-06-30: Retained Earnings (Accumulated Deficit) -$173.16M; Retained Earnings (Accumulated Deficit) as first filed -$167.36M.
- 2020-12-31: Retained Earnings (Accumulated Deficit) -$148.24M.
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$117.74M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2021-12-31 | -$180.17M 20-F · filed 2022-03-31 | $173.20M 6-K/A · filed 2022-02-18 |
| 2021-06-30 | -$173.16M 6-K/A · filed 2022-02-18 | -$167.36M 6-K · filed 2021-10-01 |
| 2020-12-31 | -$148.24M 20-F · filed 2022-03-31 | |
| 2019-12-31 | -$117.74M 20-F/A · filed 2021-04-30 |